{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:09:55Z","timestamp":1782472195127,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00428-024-03787-8","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T03:02:08Z","timestamp":1710817328000},"page":"323-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic implications of tumor histology and microenvironment in surgically resected intrahepatic cholangiocarcinoma: a single institutional experience"],"prefix":"10.1007","volume":"486","author":[{"given":"Irene Y.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-0632","authenticated-orcid":false,"given":"Xiaoyan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"3787_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.5858\/arpa.2020-0032-RA","volume":"145","author":"X Liao","year":"2021","unstructured":"Liao X, Zhang D (2021) The 8th Edition American Joint Committee on Cancer Staging for Hepato-pancreato-biliary Cancer: a review and update. Arch Pathol Lab Med 145:543\u2013553. https:\/\/doi.org\/10.5858\/arpa.2020-0032-RA","journal-title":"Arch Pathol Lab Med"},{"key":"3787_CR2","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","volume":"33","author":"T Patel","year":"2001","unstructured":"Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353\u20131357. https:\/\/doi.org\/10.1053\/jhep.2001.25087","journal-title":"Hepatology"},{"key":"3787_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/IJGM.S186854","volume":"12","author":"M Alsaleh","year":"2019","unstructured":"Alsaleh M, Leftley Z, Barbera TA, Sithithaworn P, Khuntikeo N, Loilome W, Yongvanit P, Cox IJ, Chamodol N, Syms RR, Andrews RH, Taylor-Robinson SD (2019) Cholangiocarcinoma: a guide for the nonspecialist. Int J Gen Med 12:13\u201323. https:\/\/doi.org\/10.2147\/IJGM.S186854","journal-title":"Int J Gen Med"},{"key":"3787_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.24351","volume":"54","author":"GL Tyson","year":"2011","unstructured":"Tyson GL, El-Serag HB (2011) Risk factors for cholangiocarcinoma. Hepatology 54:173\u2013184. https:\/\/doi.org\/10.1002\/hep.24351","journal-title":"Hepatology"},{"key":"3787_CR5","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","volume":"76","author":"L Izquierdo-Sanchez","year":"2022","unstructured":"Izquierdo-Sanchez L, Lamarca A, La Casta A, Buettner S, Utpatel K, Klumpen HJ, Adeva J, Vogel A, Lleo A, Fabris L, Ponz-Sarvise M, Brustia R, Cardinale V, Braconi C, Vidili G, Jamieson NB, Macias RI, Jonas JP, Marzioni M, Holowko W, Folseraas T, Kupcinskas J, Sparchez Z, Krawczyk M, Krupa L, Scripcariu V, Grazi GL, Landa-Magdalena A, Ijzermans JN, Evert K, Erdmann JI, Lopez-Lopez F, Saborowski A, Scheiter A, Santos-Laso A, Carpino G, Andersen JB, Marin JJ, Alvaro D, Bujanda L, Forner A, Valle JW, Koerkamp BG, Banales JM (2022) Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry. J Hepatol 76:1109\u20131121. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.010","journal-title":"J Hepatol"},{"key":"3787_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17:557\u2013588. https:\/\/doi.org\/10.1038\/s41575-020-0310-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3787_CR7","doi-asserted-by":"publisher","first-page":"776863","DOI":"10.3389\/fonc.2021.776863","volume":"11","author":"Y Bekki","year":"2021","unstructured":"Bekki Y, Von Ahrens D, Takahashi H, Schwartz M, Gunasekaran G (2021) Recurrent Intrahepatic Cholangiocarcinoma - Review. Front Oncol 11:776863. https:\/\/doi.org\/10.3389\/fonc.2021.776863","journal-title":"Front Oncol"},{"key":"3787_CR8","doi-asserted-by":"publisher","unstructured":"Jiang B-G, Sun L-L, Yu W-L, Tang Z-H, Zong M, Zhang Y-J (2009) Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma. Cancer J 15(3):257\u2013261. https:\/\/doi.org\/10.1097\/PPO.0b013e31819e3312","DOI":"10.1097\/PPO.0b013e31819e3312"},{"key":"3787_CR9","volume-title":"WHO classification of tumors: digestive system tumours","author":"Board WCoTE","year":"2019","unstructured":"WCoTE Board (2019) WHO classification of tumors: digestive system tumours, 5th edn. International Agency for Research on Cancer, Lyon, France","edition":"5"},{"key":"3787_CR10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","volume":"27","author":"JY Liau","year":"2014","unstructured":"Liau JY, Tsai JH, Yuan RH, Chang CN, Lee HJ, Jeng YM (2014) Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features. Mod Pathol 27:1163\u20131173. https:\/\/doi.org\/10.1038\/modpathol.2013.241","journal-title":"Mod Pathol"},{"key":"3787_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/hep.28818","volume":"65","author":"P Kaminsky","year":"2017","unstructured":"Kaminsky P, Preiss J, Sasatomi E, Gerber DA (2017) Biliary adenofibroma: a rare hepatic lesion with malignant features. Hepatology 65:380\u2013383. https:\/\/doi.org\/10.1002\/hep.28818","journal-title":"Hepatology"},{"key":"3787_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.humpath.2017.08.004","volume":"67","author":"A Bhalla","year":"2017","unstructured":"Bhalla A, Mann SA, Chen S, Cummings OW, Lin J (2017) Histopathological evidence of neoplastic progression of von Meyenburg complex to intrahepatic cholangiocarcinoma. Hum Pathol 67:217\u2013224. https:\/\/doi.org\/10.1016\/j.humpath.2017.08.004","journal-title":"Hum Pathol"},{"key":"3787_CR13","doi-asserted-by":"publisher","unstructured":"Liau JY, Tsai JH, Yuan RH, Chang CN, Lee HJ, Jeng YM (2014) Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features. Mod Pathol\u00a0 27(8):1163\u20131173. https:\/\/doi.org\/10.1038\/modpathol.2013.241","DOI":"10.1038\/modpathol.2013.241"},{"key":"3787_CR14","doi-asserted-by":"publisher","unstructured":"Sigel CS, Drill E, Zhou Y, Basturk O, Askan G, Pak LM, Vakiani E, Wang T, Boerner T, Do RKG, Simpson AL, Jarnagin W, Klimstra DS (2018) Intrahepatic cholangiocarcinomas have histologically and immunophenotypically distinct small and large duct patterns. Am J Surg Pathol 42(10):1334\u20131345. https:\/\/doi.org\/10.1097\/PAS.0000000000001118","DOI":"10.1097\/PAS.0000000000001118"},{"key":"3787_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3350\/cmh.2014.20.2.214","volume":"20","author":"JY Choe","year":"2014","unstructured":"Choe JY, Kim H (2014) Intrahepatic cholangiocarcinoma with predominant ductal plate malformation pattern. Clin Mol Hepatol 20:214\u2013217. https:\/\/doi.org\/10.3350\/cmh.2014.20.2.214","journal-title":"Clin Mol Hepatol"},{"key":"3787_CR16","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1097\/PAS.0b013e31826e0249","volume":"36","author":"Y Nakanuma","year":"2012","unstructured":"Nakanuma Y, Sato Y, Ikeda H, Harada K, Kobayashi M, Sano K, Uehara T, Yamamoto M, Ariizumi S, Park YN, Choi JH, Yu E (2012) Intrahepatic cholangiocarcinoma with predominant \u201cductal plate malformation\u201d pattern: a new subtype. Am J Surg Pathol 36:1629\u20131635. https:\/\/doi.org\/10.1097\/PAS.0b013e31826e0249","journal-title":"Am J Surg Pathol"},{"key":"3787_CR17","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1097\/PAS.0000000000001729","volume":"45","author":"P Argani","year":"2021","unstructured":"Argani P, Palsgrove DN, Anders RA, Smith SC, Saoud C, Kwon R, Voltaggio L, Assarzadegan N, Oshima K, Rooper L, Matoso A, Zhang L, Cantarel BL, Gagan J, Antonescu CR (2021) A novel NIPBL-NACC1 gene fusion is characteristic of the cholangioblastic variant of intrahepatic cholangiocarcinoma. Am J Surg Pathol 45:1550\u20131560. https:\/\/doi.org\/10.1097\/PAS.0000000000001729","journal-title":"Am J Surg Pathol"},{"key":"3787_CR18","doi-asserted-by":"publisher","first-page":"857140","DOI":"10.3389\/fmed.2022.857140","volume":"9","author":"T Chung","year":"2022","unstructured":"Chung T, Park YN (2022) Up-to-date pathologic classification and molecular characteristics of intrahepatic cholangiocarcinoma. Front Med (Lausanne) 9:857140. https:\/\/doi.org\/10.3389\/fmed.2022.857140","journal-title":"Front Med (Lausanne)"},{"key":"3787_CR19","volume-title":"AJCC Cancer Staging Manual","author":"MBES Amin","year":"2017","unstructured":"Amin MBES, Greene F et al (2017) AJCC Cancer Staging Manual, 8th edn. Springer, New York, NY","edition":"8"},{"issue":"Suppl 1","key":"3787_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hep.31410","volume":"73","author":"L Fabris","year":"2021","unstructured":"Fabris L, Sato K, Alpini G, Strazzabosco M (2021) The tumor microenvironment in cholangiocarcinoma progression. Hepatology 73(Suppl 1):75\u201385. https:\/\/doi.org\/10.1002\/hep.31410","journal-title":"Hepatology"},{"key":"3787_CR21","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27:5904\u20135912. https:\/\/doi.org\/10.1038\/onc.2008.271","journal-title":"Oncogene"},{"key":"3787_CR22","doi-asserted-by":"publisher","unstructured":"Ruffolo LA-O, Jackson KM, Kuhlers PC, Dale BS, Figueroa Guilliani NM, Ullman NA, Burchard PR, Qin SS, Juviler PG, Keilson JM, Morrison AB, Georger M, Jewell R, Calvi LM, Nywening TM, O'Dell MR, Hezel AA-O, De Las Casas L, Lesinski GA-O, Yeh JJ, Hernandez-Alejandro R, Belt BA, Linehan DC (2022) GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity. Gut 71(7):1386\u20131398. https:\/\/doi.org\/10.1136\/gutjnl-2021-324109","DOI":"10.1136\/gutjnl-2021-324109"},{"key":"3787_CR23","doi-asserted-by":"publisher","unstructured":"Zhang M, Yang H, Wan L, Wang Z, Wang H, Ge C, Liu Y, Hao Y, Zhang D, Shi G, Gong Y, Ni Y, Wang C, Zhang Y, Xi J, Wang S, Shi L, Zhang L, Yue W, Pei X, Liu B, Yan X (2020) Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma. J Hepatol 73(5):1118\u20131130. https:\/\/doi.org\/10.1016\/j.jhep.2020.05.039","DOI":"10.1016\/j.jhep.2020.05.039"},{"key":"3787_CR24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/hep.31092","volume":"72","author":"S Job","year":"2020","unstructured":"Job S, Rapoud D, Dos Santos A, Gonzalez P, Desterke C, Pascal G, Elarouci N, Ayadi M, Adam R, Azoulay D, Castaing D, Vibert E, Cherqui D, Samuel D, Sa Cuhna A, Marchio A, Pineau P, Guettier C, de Reynies A, Faivre J (2020) Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma. Hepatology 72:965\u2013981. https:\/\/doi.org\/10.1002\/hep.31092","journal-title":"Hepatology"},{"key":"3787_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ajcp\/aqac001","volume":"158","author":"D Zhang","year":"2022","unstructured":"Zhang D, Love T, Hao Y, Liu BL, Thung S, Fiel MI, Whitney-Miller CL, Liao X (2022) Tumor size, not small vessel invasion, predicts survival in patients with hepatocellular carcinoma. Am J Clin Pathol 158:70\u201380. https:\/\/doi.org\/10.1093\/ajcp\/aqac001","journal-title":"Am J Clin Pathol"},{"key":"3787_CR26","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.3748\/wjg.14.2251","volume":"14","author":"YM Zhou","year":"2008","unstructured":"Zhou YM, Yang JM, Li B, Yin ZF, Xu F, Wang B, Liu P, Li ZM (2008) Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein. World J Gastroenterol 14:2251\u20132254. https:\/\/doi.org\/10.3748\/wjg.14.2251","journal-title":"World J Gastroenterol"},{"key":"3787_CR27","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1038\/s41598-021-83149-5","volume":"11","author":"TH Yu","year":"2021","unstructured":"Yu TH, Chen X, Zhang XH, Zhang EC, Sun CX (2021) Clinicopathological characteristics and prognostic factors for intrahepatic cholangiocarcinoma: a population-based study. Sci Rep 11:3990. https:\/\/doi.org\/10.1038\/s41598-021-83149-5","journal-title":"Sci Rep"},{"key":"3787_CR28","unstructured":"Jansson H, Villard C, Nooijen LE, Ghorbani P, Erdmann JI, Sparrelid E Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis"},{"key":"3787_CR29","unstructured":"Klimstra DS ZY, Komuta M (2019) Intrahepatic cholangiocarcinoma WHO Classification of Tumours Editorial Board. Digestive system tumours [Internet], 5th.edn. International Agency for Research on Cancer, Lyon (France), pp 254\u2013259"},{"key":"3787_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1177\/1066896918758172","volume":"26","author":"D Chua","year":"2018","unstructured":"Chua D, Chiow AKH, Ang TL, Wang LM (2018) Malignant transformation arising within unusual and rare hepatic lesions: fibropolycystic disease form of ductal plate malformation and biliary adenofibroma. Int J Surg Pathol 26:542\u2013550. https:\/\/doi.org\/10.1177\/1066896918758172","journal-title":"Int J Surg Pathol"},{"key":"3787_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000184909","volume":"48","author":"J Schrader","year":"1988","unstructured":"Schrader J, Gallimore MJ, Eisenhauer T, Isemer FE, Schoel G, Warneke G, Bruggemann M, Scheler F (1988) Parameters of the kallikrein-kinin, coagulation and fibrinolytic systems as early indicators of kidney transplant rejection. Nephron 48:183\u2013189. https:\/\/doi.org\/10.1159\/000184909","journal-title":"Nephron"},{"key":"3787_CR32","doi-asserted-by":"publisher","unstructured":"Monu NR, Frey AB (2012) Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship. Immunol Invest 41(6-7):595\u2013613. https:\/\/doi.org\/10.3109\/08820139.2012.673191","DOI":"10.3109\/08820139.2012.673191"},{"key":"3787_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1200\/jco.2016.34.4_suppl.273","volume":"34","author":"RF Dunne","year":"2016","unstructured":"Dunne RF, Figueroa N, Belt B, Findeis-Hosey J, Lunt M, Ye J, McMahon L, Baran A, Shubin A, Noel MS, Tejani MA, Hezel AF, Linehan D (2016) The role of myeloid derived suppressor cells in cholangiocarcinoma: a potential target for therapy. J Clin Oncol 34:273\u2013273. https:\/\/doi.org\/10.1200\/jco.2016.34.4_suppl.273","journal-title":"J Clin Oncol"},{"key":"3787_CR34","doi-asserted-by":"publisher","unstructured":"Lozada ME, Zhang N, Jin W, Wongjarupong N, Yang JD, Voss MM, Prasai K, Amakye DO, Harmsen WS, Chaudhary S, Bathe OF, Borad MJ, Patel TC, Gores GJ, Therneau TM, Roberts LR (2023) CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation. Am J Gastroenterol 118(12):2173\u20132183. https:\/\/doi.org\/10.14309\/ajg.0000000000002258","DOI":"10.14309\/ajg.0000000000002258"},{"key":"3787_CR35","doi-asserted-by":"publisher","first-page":"3537471","DOI":"10.1155\/2018\/3537471","volume":"2018","author":"SY Lee","year":"2018","unstructured":"Lee SY, Ju MK, Jeon HM, Jeong EK, Lee YJ, Kim CH, Park HG, Han SI, Kang HS (2018) Regulation of tumor progression by programmed necrosis. Oxid Med Cell Longev 2018:3537471. https:\/\/doi.org\/10.1155\/2018\/3537471","journal-title":"Oxid Med Cell Longev"},{"key":"3787_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-3-030-35727-6_6","volume":"1225","author":"A Karsch-Bluman","year":"2020","unstructured":"Karsch-Bluman A, Benny O (2020) Necrosis in the tumor microenvironment and its role in cancer recurrence. Adv Exp Med Biol 1225:89\u201398. https:\/\/doi.org\/10.1007\/978-3-030-35727-6_6","journal-title":"Adv Exp Med Biol"},{"key":"3787_CR37","doi-asserted-by":"publisher","first-page":"11166","DOI":"10.1002\/cam4.5742","volume":"12","author":"S Yang","year":"2023","unstructured":"Yang S, Hu H, Hu Y, Dai Y, Zou R, Lv T, Li F (2023) Is tumor necrosis a clinical prognostic factor in hepato-biliary-pancreatic cancers? A Syst Rev Meta-Anal Cancer Med 12:11166\u201311176. https:\/\/doi.org\/10.1002\/cam4.5742","journal-title":"A Syst Rev Meta-Anal Cancer Med"},{"key":"3787_CR38","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-11462-y","author":"DI Tsilimigras","year":"2022","unstructured":"Tsilimigras DI, Ejaz A, Cloyd J, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Endo I, Pawlik TM (2022) Tumor necrosis impacts prognosis of patients undergoing resection for T1 intrahepatic cholangiocarcinoma. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-022-11462-y","journal-title":"Ann Surg Oncol"},{"key":"3787_CR39","doi-asserted-by":"publisher","unstructured":"Kojima S, Hisaka T, Midorikawa R, Naito Y, Akiba J, Tanigawa M, Yano H, Akagi Y, Okuda K (2020) Prognostic impact of desmoplastic reaction evaluation for intrahepatic cholangiocarcinoma. Anticancer Res 40(8):4749\u20134754. https:\/\/doi.org\/10.21873\/anticanres.14476","DOI":"10.21873\/anticanres.14476"},{"key":"3787_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.humpath.2017.04.014","volume":"65","author":"X-f Zhang","year":"2017","unstructured":"Zhang X-f, Dong M, Pan Y-H, Chen J-N, Huang X-Q, Jin Y, Shao C-K (2017) Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma. Human Pathol 65:92\u2013100. https:\/\/doi.org\/10.1016\/j.humpath.2017.04.014","journal-title":"Human Pathol"},{"key":"3787_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2023.01.019","author":"A Scott","year":"2023","unstructured":"Scott A, Wong P, Melstrom LG (2023) Surgery and hepatic artery infusion therapy for intrahepatic cholangiocarcinoma. Surgery. https:\/\/doi.org\/10.1016\/j.surg.2023.01.019","journal-title":"Surgery"},{"key":"3787_CR42","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J, Investigators ABCT (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273\u20131281. https:\/\/doi.org\/10.1056\/NEJMoa0908721","journal-title":"N Engl J Med"},{"key":"3787_CR43","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S2468-1253(22)00043-7","volume":"7","author":"DY Oh","year":"2022","unstructured":"Oh DY, Lee KH, Lee DW, Yoon J, Kim TY, Bang JH, Nam AR, Oh KS, Kim JM, Lee Y, Guthrie V, McCoon P, Li W, Wu S, Zhang Q, Rebelatto MC, Kim JW (2022) Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study. Lancet Gastroenterol Hepatol 7:522\u2013532. https:\/\/doi.org\/10.1016\/S2468-1253(22)00043-7","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3787_CR44","doi-asserted-by":"publisher","unstructured":"Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, Niknafs N, Guthrie VB, Maitra A, Argani P, Offerhaus GJA, Roa JC, Roberts LR, Gores GJ, Popescu I, Alexandrescu ST, Dima S, Fassan M, Simbolo M, Mafficini A, Capelli P, Lawlor RT, Ruzzenente A, Guglielmi A, Tortora G, de Braud F, Scarpa A, Jarnagin W, Klimstra D, Karchin R, Velculescu VE, Hruban RH, Vogelstein B, Kinzler KW, Papadopoulos N, Wood LD (2013) Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 45(12):1470-1473. https:\/\/doi.org\/10.1038\/ng.2813","DOI":"10.1038\/ng.2813"},{"key":"3787_CR45","doi-asserted-by":"publisher","unstructured":"Li JH, Wu X, Ni X, Li YX, Xu L, Hao XY, Zhao W, Zhu XX, Yin XY (2023) Angiotensin receptor blockers retard the progression and fibrosis via inhibiting the viability of (AGTR1+) CAFs in intrahepatic cholangiocarcinoma. Clin Transl Med 13(3):e1213. https:\/\/doi.org\/10.1002\/ctm2.1213","DOI":"10.1002\/ctm2.1213"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03787-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-024-03787-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03787-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T13:24:21Z","timestamp":1741008261000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-024-03787-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3787"],"URL":"https:\/\/doi.org\/10.1007\/s00428-024-03787-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board at URMC (STUDY00003839).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}